The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to assess the balance of benefits and harms of screening for impaired visual acuity…
Uncategorized
VIDEO: Surgeon presents positive study results of Mydrane ophthalmic solution
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons winter meeting, Béatrice Cochener, MD, PhD, presents results from a study of Mydrane (tropicamide 0.02%, phenylephrine 0.31%, lidocaine 1%, Théa) as a fixed dose given intracamerally before cataract surgery. The study found that the combination of mydriatic and anesthetic provided fast pupil dilation and extra comfort for the patient while avoiding toxic effects of drops on the ocular surface.
Aflibercept Best in Diabetics With Bad Baseline Vision?
Final results from a trial comparing aflibercept, bevacizumab, and ranibizumab in diabetic macular edema confirm all three drugs are similar, but aflibercept is best in those with worse baseline vision, says lead researcher. Medscape Medical News
HHS Announces Agreement on Health Data Interoperability
(MedPage Today) — Providers, vendors agree to prevent information blocking, standardize programming
First Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits
DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that all subjects treated as part of the first stage of its U.S. Food and Drug Administration (FDA) pivotal study completed their 12-month postoperative visits, a significant milestone in the FDA approval process of its Presbia Flexivue Microlens™. The Presbia Flexivue Microlens is a revolutionary optical lens implant for treating presbyopia, the age-related l
Uncategorized
Técnica de bolsa é similar ao túnel para o implante de segmentos de anel corneano intraestromal
Até cerca de 15 anos atrás, os pacientes com ceratocone tinham poucas opções de tratamento disponíveis para eles: lentes de contato permeáveis a gases, em uma ponta do espectro de tratamento, e a ceratoplastia penetrante, na outra. Felizmente, hoje temos acesso a uma infinidade de tratamentos, incluindo a interligação de colágeno da córnea e a PRK orientada pela topografia.Um dos tratamentos mais interessantes para o ceratocone é a utilização de segmentos de anel corneano intraestromal (ICRS), os quais ajudam a reduzir os erros de refração, melhoram a acuidade visual e regularizam a superfície da córnea. Um crescente volume de dados de longo prazo também sugerem que o ICRS também pode ajudar a retardar ou mesmo a eliminar a necessidade de uma ceratoplastia penetrante.